Jinlong Qin - Publications

HMGA2 Mediates Uterine Fibroid Progression via MAP4-Dependent Regulation of ECM and EMT.

Journal: The Tohoku journal of experimental medicine

Published: June 24, 2026

O2-releasing microneedle platform eradicates drug-resistant bacterial biofilm via metabolic interference and innate immune reactivation.

Journal: Biomaterials

Published: January 11, 2026

Establishment of insulin resistance-related ten-gene signature in endometrial cancer and identification of ACTL8 as a prognostic and immunological biomarker.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: October 14, 2025

Solute carrier transporters in tumor metabolism and tumor immunity.

Journal: Chemico-biological interactions

Published: September 27, 2025

Maternal monocyte-derived IFN-α1 triggers early fetal demise.

Journal: Journal of translational medicine

Published: August 01, 2025

Differential modulation of gestational immunity by fatty acids: tissue-specific immune remodeling and clinical implications.

Journal: Clinical science (London, England : 1979)

Published: July 18, 2025

Redox-Regulated Phase Switchable Peptide Droplets with Degradation Resistance for Intravenous Delivery of Biopharmaceuticals.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: June 20, 2025

A Metal-Peptide Framework as a Nanozyme for the Attenuation of Amyloid‑β Aggregation and Reactive Oxygen Species.

Journal: JACS Au

Published: June 10, 2025

Association of cardiovascular health with reproductive lifespan and pregnancy loss: insights from NHANES 2005-2018.

Journal: Frontiers in endocrinology

Published: March 20, 2025

Nanoporous Plasmonic Microneedle Arrays Induced High-Efficiency Intracellular Delivery of Metabolism Regulating Protein.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: December 12, 2024

Targeting senescent cells in aged adipose tissue induced by ovarian cancer with the NF-κB inhibitor quercetin and resveratrol impedes the growth and metastasis of ovarian cancer.

Journal: Science China. Life sciences

Published: November 12, 2024

Rational design of peptides to overcome drug resistance by metabolic regulation.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: October 13, 2024